COMPASS Pathways plc

DB:5Y6 Stock Report

Market Cap: €1.6b

COMPASS Pathways Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Kabir Nath

Chief executive officer

US$2.1m

Total compensation

CEO salary percentage30.75%
CEO tenure4yrs
CEO ownership0.05%
Management average tenure3.2yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Kabir Nath's remuneration changed compared to COMPASS Pathways's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026n/an/a

-US$394m

Mar 31 2026n/an/a

-US$179m

Dec 31 2025US$2mUS$647k

-US$288m

Sep 30 2025n/an/a

-US$237m

Jun 30 2025n/an/a

-US$138m

Mar 31 2025n/an/a

-US$138m

Dec 31 2024US$4mUS$628k

-US$155m

Sep 30 2024n/an/a

-US$144m

Jun 30 2024n/an/a

-US$139m

Mar 31 2024n/an/a

-US$129m

Dec 31 2023US$3mUS$595k

-US$118m

Sep 30 2023n/an/a

-US$117m

Jun 30 2023n/an/a

-US$102m

Mar 31 2023n/an/a

-US$95m

Dec 31 2022US$8mUS$243k

-US$92m

Compensation vs Market: Kabir's total compensation ($USD2.10M) is about average for companies of similar size in the German market ($USD1.89M).

Compensation vs Earnings: Kabir's compensation has been consistent with company performance over the past year.

CEO

Kabir Nath (62 yo)

4yrs
Tenure
US$2,104,711
Compensation

Mr. Kabir Kumar Nath M. A., M. B.A., is Chief Executive Officer and Executive Director of COMPASS Pathways plc from August 1, 2022. He served as President & CEO at Otsuka America Pharmaceutical, Inc. He se...

Leadership Team

NamePositionTenureCompensationOwnership
Kabir Nath
CEO & Executive Director4yrsUS$2.10m0.047%
€ 738.8k
Teri Loxam
Chief Financial Officer2.4yrsUS$1.10m0.019%
€ 307.0k
Guy Goodwin
Chief Medical Officer5.1yrsUS$908.95k0.0014%
€ 22.8k
Stephen Schultz
Senior Vice President of Investor Relationsno datano datano data
Lars Wilde
Senior Advisor4.6yrsno datano data
Susan Stansfield
Advisorno datano datano data
Michael Gold
Chief Research & Development Officer2.3yrsno datano data
Lori Englebert
Chief Commercial Officer2.1yrsno datano data
Steve Levine
Chief Patient Officer1.6yrsno datano data
Benjamin Harber
Company Secretary5.3yrsno datano data
3.2yrs
Average Tenure
53yo
Average Age

Experienced Management: 5Y6's management team is considered experienced (3.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kabir Nath
CEO & Executive Director4yrsUS$2.10m0.047%
€ 738.8k
Alan Schatzberg
Member of Scientific Advisory Networkno datano datano data
Gino Santini
Independent Chairman1.9yrsUS$232.80k0%
€ 0
David Norton
Independent Director8.3yrsUS$134.74k0.015%
€ 232.4k
Daphne Karydas
Independent Director2.9yrsUS$145.83k0%
€ 0
Robert McQuade
Independent Non Executive Director6yrsUS$143.87k0%
€ 0
Wayne Riley
Independent Non-Executive Director5.4yrsUS$136.20k0%
€ 0
Diego Pizzagalli
Member of Scientific Advisory Networkno datano datano data
Gul Dolen
Member of Scientific Advisory Networkno datano datano data
Kirk Rutter
Special Advisor of Patient Experienceno datano datano data
John Rush
Member of Scientific Advisory Networkno datano datano data
Paul Summergrad
Member of Scientific Advisory Networkno datano datano data
4.7yrs
Average Tenure
69yo
Average Age

Experienced Board: 5Y6's board of directors are considered experienced (4.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/24 09:55
End of Day Share Price 2026/08/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

COMPASS Pathways plc is covered by 22 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madison Wynne El-SaadiB. Riley Securities, Inc.
Thomas ShraderBTIG
Sumant Satchidanand KulkarniCanaccord Genuity